Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yasser Khazaal, Lausanne university, Switzerland

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist and researcher with extensive experience in addiction psychiatry. He earned his MD from René Descartes, Paris V, and Swiss Board Certification in Psychiatry and Psychotherapy. Currently, he is a Full Professor at the University of Lausanne, Switzerland, and holds multiple roles including Associate Researcher at Montreal University. Prof. Khazaal’s research focuses on cognitive behavioral therapies, game-based interventions, and the development of smartphone apps for addiction treatment. He has published extensively on addictive disorders and is a key figure in international psychiatric societies. 🏥📚🔬

Publication Profile

google scholar

Education

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist with an impressive academic background. He earned his MD from René Descartes, Paris V, France, in 1998. In 2005, he achieved Swiss Board Certification in Psychiatry and Psychotherapy. His expertise and contributions were further recognized with his appointment as a Privat Docent (senior lecturer) at Geneva University in 2009. Dr. Khazaal is known for his work in psychiatry and psychotherapy, holding a prominent position in the academic and clinical communities in Switzerland. 🌐🩺📚

Employment History

Prof. Dr. Yasser Khazaal has an extensive background in addiction psychiatry. From 2003 to 2005, he served as a senior psychiatrist and head of the mood and anxiety disorders outpatient unit at Lausanne University Hospital. From 2007 to 2018, he was the deputy head of the Addiction clinic at Geneva University Hospitals. Over the years, he held successive academic appointments at Geneva University, Switzerland, eventually becoming a full professor of addiction psychiatry at the Faculty of Biology and Medicine, University of Lausanne since 2019. He is also a member of the board of Addiction medicine at Lausanne University Hospital. Prof. Khazaal is an associate researcher at the Montreal University Institute of Mental Health, Canada, and an associate professor at the Department of Psychiatry and Addiction, Montreal University, Canada. Additionally, he served as a visiting professor at Kazimierz Wielki University, Poland, in 2022, as part of a project co-financed by the European Union. 📘🔍🌍

Teaching

Prof. Dr. Yasser Khazaal has extensive experience in teaching medical students at both the University of Lausanne (2003-2007, 2019-2023) and the University of Geneva (2007-2018). His teaching portfolio includes courses on mood and anxiety disorders (2003-2007), psychopharmacology (2006-2007), addiction (2019-2023), and community research in practice (2021-2023). He has also taught and supervised clinical cognitive and behavior therapy (CBT) skills (2018-2023), CBT for bipolar disorder (2007), CBT for mood disorders (2005-2006), and CBT of impulsive behaviors (2020). Prof. Dr. Khazaal is committed to integrating clinical teaching and practice in his courses. 📚💬🧠

Grants 

Prof. Dr. Yasser Khazaal is a leading researcher in addiction and mental health, with extensive funding from various Swiss and international sources. His projects include studies on cognitive behavioral interventions for psychosis, mood and anxiety disorders, smoking cessation, and smartphone applications for addiction treatment. Key grants include the Swiss National Science Foundation (268,426 CHF) and Astra-Zeneca (140,000 CHF) for LACOSMA, as well as research on “Impact of Pick Klop game on smoking cessation” (172,500 CHF) and smartphone applications (194,942 CHF). He collaborates internationally on projects such as managing trauma exposure in Congo (12,125 Euros) and the “Sesame” serious game for mental health (20,000 CHF). His work continues to advance the field with a focus on innovative and practical solutions to addiction and mental health challenges. 🧠💊🚬

Conferences and Awards

Prof. Dr. Yasser Khazaal is a distinguished academic and leader in the field of social psychiatry. He served as the Chair for the European Congress of Social Psychiatry in 2012, 2015, and 2018. He was also the Co-chair for the International Conference of Behavioral Addictions in 2016, held in Geneva, Switzerland. More recently, he co-chaired the Challenges of Ecology Related to Mental Health conference in Athens in 2022. In recognition of his contributions, he was elected an Honorary Fellow of the World Association of Social Psychiatry in 2013. 🌍🔍💬

Scientific Achievements

Prof. Dr. Yasser Khazaal is a renowned expert in addiction studies, focusing on game-based interventions, including delusions and smoking cessation. He has contributed significantly to the development of smartphone app interventions for addictive disorders and mood regulation. Prof. Khazaal has published extensively on the assessment and psychopathology of addictive disorders. He also leads research on Recovery Oriented Services, exploring community interventions and peer support initiatives. 🌱📱🚭📚

Research Focus

Yasser Khazaal is a researcher primarily focused on behavioral addictions, particularly in the context of online gaming and internet use. His work explores how common behaviors can become problematic without necessarily being pathologized as addiction. He investigates self-reported motivations behind playing online games, such as World of Warcraft, and examines problematic involvement in these games using various psychological and survey methods. Khazaal’s research aims to refine the understanding of behavioral addiction and its implications for mental health, with a particular interest in the validation and adaptation of assessment tools for addictive behaviors in digital environments. 💻🕹️📊

Publication Top notes

Are we overpathologizing everyday life? A tenable blueprint for behavioral addiction research

How can we conceptualize behavioural addiction without pathologizing common behaviours?

Why do you play World of Warcraft? An in-depth exploration of self-reported motivations to play online and in-game behaviours in the virtual world of Azeroth

French validation of the internet addiction test

Validation of a short French version of the UPPS-P Impulsive Behavior Scale

Problematic involvement in online games: A cluster analytic approach

Does self-selection affect samples’ representativeness in online surveys? An investigation in online video game research

Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey

 

 

 

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Mr Alfonso Luca Pendolino, University College London, United Kingdom

Based on Mr. Alfonso Luca Pendolino’s experience and research, he could be considered a strong candidate for the Best Researcher Award. Here’s why:

Publication profile

Scopus

Education

From October 2021, a part-time PhD student at UCL’s Ear Institute focused on olfactory dysfunction in chronic respiratory diseases. Clinical Fellow at the Royal National Throat, Nose & Ear Hospital, London. Delivered oral presentations at ERS Thessaloniki 2021 on nasal septal perforation repair and the triple-layer technique. Earned a diploma in Otorhinolaryngology from the University of Padova with magna cum laude honors. Actively engaged in various courses, including Balloon Sinuplasty in Guildford and Smell and Taste 11 in Dresden. Member of ENT UK and the British Rhinological Society, with scientific habilitation in Italy. ✨👃📚💼

Experience

From October 2023 to October 2024, the user works as a Senior Clinical Fellow at St George’s University Hospital NHS Foundation Trust in Ear, Nose, and Throat Surgery, focusing on rhinology and anterior skull base procedures. From February 2019 to October 2023, they held a similar role at the Royal National Throat, Nose and Ear Hospital, part of University College London Hospitals. Since October 2019, they have also been pursuing a PhD in the Ear Institute at University College London, focusing on research. Previously, from December 2014 to December 2018, they trained as a resident in Otolaryngology at the University of Padova. 🎓🩺📊

Expertise and Contributions

Mr. Pendolino has extensive clinical and academic experience in Ear, Nose, and Throat (ENT) surgery, particularly in rhinology and anterior skull base procedures. His work spans senior clinical fellowships at prestigious institutions like St. George’s University Hospital and the Royal National Throat, Nose, and Ear Hospital, combined with a PhD research focus on olfactory dysfunction at the University College London (UCL). This academic engagement showcases his commitment to advancing medical science, specifically in rhinology.

Notable Research and Publications

He has contributed significantly to academic research, authoring several impactful papers on topics such as nasal septal perforation repair, cocaine-induced destructive lesions, and smell loss related to COVID-19. His recent publications in high-impact journals such as Diagnostics and Laryngoscope address both clinical outcomes and advanced ENT techniques, demonstrating a broad impact on both scientific understanding and patient care.

Continuous Learning and Development

Throughout his career, Mr. Pendolino has pursued a range of certifications and courses, from endoscopic skull base surgery to rhinoplasty, which highlights his dedication to continual professional development. His involvement in international conferences, including oral communications and workshops, further positions him as a leader in his field.

Research Impact

Although many of his papers have limited citations due to their recent publication, his research has already influenced surgical practices and patient outcomes, especially concerning sinus surgery and chronic respiratory disease management.

conclusion

Mr. Pendolino’s combination of clinical expertise, high-quality research, and ongoing contributions to ENT surgery make him a commendable candidate for the Best Researcher Award.

Publication top notes

Objective and Subjective Outcomes Following Radiofrequency of Inferior Turbinates in Patients with Sleep-Disordered Breathing

The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy

Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year

The role of large cavity sinus surgery in the management of chronic rhinosinusitis in non-steroidal anti-inflammatory drug exacerbated respiratory disease: A single-centre experience and long-term outcomes

Reply to: Letter to the editor regarding “Long-term quality-of-life impairment in patients with more than 1-year COVID-19–related olfactory dysfunction”

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …